Get started
Author

Naomi Earl

Observed name: N Earl
ORCID: 0000-0002-4261-3900
Observed ORCID: 0000-0002-4261-3900
OpenAlex ID: A5076022271
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 45
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 42
PDF
Severe progression of idiopathic pulmonary fibrosis post-COVID-19 infection
2021 · Naomi Earl, Dillon Schoeneberg, et al. · BMJ Case Reports · 8
PDF
Lung ultrasound as a tool for monitoring the interstitial changes in recently hospitalised patients with COVID-19 pneumonia - The COVIDLUS study
2023 · Tuck-Kay Loke, Naomi Earl, et al. · Respiratory Medicine · 5
PDF
Hypercapnic respiratory failure in pregnancy: A rare presentation of a congenital myopathy
2025 · Naomi Earl, Guy Chivers, et al. · Obstetric Medicine
TB: Tip of the iceberg or a pandemic in the making - again?
2024 · Naomi Earl, Burhan Khan, et al. · European Respiratory Journal
Lung Ultrasound as a tool for monitoring the interstitial changes in recently hospitalised patients with COVID-19 pneumonia - the COVIDLUS study
2022 · N Earl, A Begbey, et al. · European Respiratory Journal
P214 A normal CT chest negates the need for bronchoscopy for the detection of covert malignancy in patients presenting with haemoptysis through the two-week-wait pathway; a retrospective study from a district general hospital
2021 · N Earl, A Begbey, et al. · Thorax
Works count: 10
Citation count: 177
H-index: 5
I10-index: 4
Year
Topic
Type